Nanology – Advancing Intratumoral Drug Therapy
  • About
    • Overview
    • Team & Advisors
    • Partnering Opportunities
  • Technology
  • Development
    • Products
    • Pipeline
    • Clinical Programs
    • Immunogenic Effect
    • Partnering Opportunities
  • News & Publications
  • Contact
    • Partnering Opportunities
    • Physicians and Patients
logo

Archive for the NanOlogy Events Category

September 27-30: AACR Special Conference: Pancreatic Cancer | Boston

On April 10, 2023   /   NanOlogy Events  

AACR Special Conference: Pancreatic Cancer

Dates:  September 27-30 , 2023
Location: Boston

Event Website:  AACR Special Conference

 

Back to Top

November 1-5: SITC – 38th Annual Meeting Society for Immunotherapy of Cancer | San Diego

On April 10, 2023   /   NanOlogy Events  

SITC 2023 – 38th Annual Meeting of the Society for Immunotherapy of Cancer

Dates:  November 1-5, 2023
Location: San Diego

Event Website:  SITC

 

Back to Top

December 1-3: IASLC 2023 – North American Conference on Lung Cancer| Chicago

On April 10, 2023   /   NanOlogy Events  

IASLC 2023 – North American Conference on Lung Cancer

Dates:  December 1-3, 2023
Location: Chicago

Event Website: IASLC

 

Back to Top

Recent Nanology News

  • NanOlogy Announces Two Abstracts Have Been Accepted for Presentation at AACR Special Conference in Cancer Research: Pancreatic Cancer September 12, 2023
  • Cancers: The Role of Therapeutic Endoscopic Ultrasound in Pancreatic Cancer: An Endoscopic Oncologists Perspective June 28, 2023
  • ASCO 2023 Abstract: Safety of locally administered large surface area microparticle paclitaxel and docetaxel in combination with standard of care cancer therapies June 8, 2023
  • NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparticle Investigational Drugs June 7, 2023
  • DDW 2023 Poster: Intracystic Injection of Large Surface Area Microparticle Paclitael for Chemoablation of Intraductal Papillary Mucinous Neoplasms: Insights from an Expanded Access Protocol May 25, 2023

Home
About
Technology
Development
News & Publications
Contact

NanOlogy investigational drugs have not yet been proven to be safe and effective in accordance with the requirements of the U.S. FDA and are not approved by FDA or any other jurisdiction for commercial distribution. NanOlogy, NanoPac, and NanoDoce are trademarks of NanOlogy, LLC.

© 2017-23 NanOlogy LLC     Legal
Back to Top
This website uses cookies to improve your experience. By clicking "Accept", you consent to the use of ALL the cookies. However you may visit the Cookie Settings to provide a controlled consent. Cookie settings ACCEPT
Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

This is an necessary category.

Non Necessary

This is an non-necessary category.

Save & Accept